Annual Drug Patent Expirations for TRICOR
Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in three NDAs. It is available from five suppliers. There are three patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for TRICOR.
This drug has one hundred and fifty-five patent family members in twenty-seven countries.
The generic ingredient in TRICOR is fenofibrate. Five suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
